Evidence map›Paper›PMID 33889525›Full record

ArticleTranslational lung cancer research2021

Increased detection of circulating tumor DNA by short fragment enrichment.

Yang Liu, Yangyang Liu, Yingying Wang, Lei Li, Wenjun Yao, Yingnan Song, Bing Liu, Weihuang Chen, Mariacarmela Santarpia, Elisabetta Rossi and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Translational lung cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Circulating Tumor DNA in Pediatric Cancer.Frontiers in molecular biosciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Yang LiuDepartment of Radiotherapy, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Yangyang LiuDepartment of Laboratory Technology Development, Global Medical Product Center (GMPC), Beijing Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
Yingying WangDepartment of Laboratory Technology Development, Global Medical Product Center (GMPC), Beijing Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
Lei LiDepartment of Laboratory Technology Development, Global Medical Product Center (GMPC), Beijing Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
Wenjun YaoDepartment of Laboratory Technology Development, Global Medical Product Center (GMPC), Beijing Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
Yingnan SongDepartment of Laboratory Technology Development, Global Medical Product Center (GMPC), Beijing Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
Bing LiuDepartment of Laboratory Technology Development, Global Medical Product Center (GMPC), Beijing Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
Weihuang ChenDepartment of Laboratory Technology Development, Global Medical Product Center (GMPC), Beijing Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
Mariacarmela SantarpiaMedical Oncology Unit, Department of Human Pathology of Adult and Evolutive Age "G. Barresi", University of Messina, Messina, Italy.
Elisabetta RossiVeneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Rita ZamarchiVeneto Institute of Oncology IOV-IRCCS, Padova, Italy.
Zhe WangDepartment of Medical Oncology Affiliated Zhongshan Hospital of Dalian University, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Qiming WangDepartment of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
Gang ChengDepartment of Laboratory Technology Development, Global Medical Product Center (GMPC), Beijing Novogene Bioinformatics Technology Co., Ltd., Beijing, China.
Novogene Bioinformatics Institute · CNZhengzhou University · CNAffiliated Zhongshan Hospital of Dalian University · CNIstituto Oncologico Veneto · ITUniversity of Messina · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCirculating cell-free DNA (cfDNA) detection for non-invasive diagnosis requires higher sensitivity and accuracy due to the low circulating tumor DNA (ctDNA) content. Many methods have been developed to improve detection of ctDNA, including ultra-deep sequencing or enrichment of shorter cfDNA fragments, such as those in the range of 90-150 bp.

methodsHere, we developed a method for single-stranded DNA (ssDNA) library preparation with a large proportion of magnetic beads to enrich the shorter cfDNA fragments. We aimed to determine if this could increase the ctDNA content and thus improve the sensitivity of ctDNA detection by testing the method in blood samples from patients with advanced cancers (non-small cell lung cancers, esophageal squamous cell carcinoma, cholangiocarcinoma, colorectal cancer and liver cancer).

resultsThis method was able to obtain shorter cfDNA both in commercial cfDNA references and real world clinical cfDNA samples. Plasmid simulation experiments showed that using a large proportion of magnetic beads to construct the library could obtain more ctDNA derived from shorter-fragment plasmids, which could significantly improve the detection of ctDNA especially in the low-variant allele frequency sample. In real-world clinical samples, this method may be able to increase the opportunity to obtain alteration reads from short fragments, which was important to low frequency detection.

conclusionsThe ssDNA library preparation with large proportion of magnetic beads could increase the opportunity to obtain alteration reads from short fragments, which is crucial for low variant allele frequency detection.

Indexed as

Cell-free DNA (cfDNA)circulating tumor DNA enrichment (ctDNA enrichment)ctDNA detectionsingle-strand DNA library preparation (ssDNA library preparation)

Identifiers

PMID33889525
PMCPMC8044499
OpenAlexW3140063593

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.